Skip to main content
. 2022 Sep 30;14(1):58–66. doi: 10.1111/jdi.13910

Table 2.

Agreement between the insulinoma‐associated antigen‐2 by radioimmunoassay and the insulinoma‐associated‐2 by enzyme‐linked immunosorbent assay with sera from type 1 diabetes

Type 1 diabetic patients n RIA (+) ELISA (+) Agreement κ statistics (95% CI)
Fulminant type 1 diabetes 38 0 (0%) 2 (5%) 94.7% 0.000 (0.000–0.000)
Acute‐onset type 1 diabetes 168 85 (51%) 77 (46%) 89.3% 0.786 (0.693–0.879)
SPIDDM 137 42 (31%) 37 (27%) 90.5% 0.769 (0.651–0.888)

CI, confidence interval; ELISA, enzyme‐linked immunosorbent assay; RIA, radioimmunoassay; SPIDDM, slowly‐progressive type 1 diabetes.